nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—acquired immunodeficiency syndrome—sarcoma	0.729	1	CtDrD
Efavirenz—CYP2B6—Thiotepa—sarcoma	0.0788	0.412	CbGbCtD
Efavirenz—CYP1A2—Dacarbazine—sarcoma	0.0256	0.134	CbGbCtD
Efavirenz—CYP3A4—Thiotepa—sarcoma	0.0242	0.126	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—sarcoma	0.0146	0.0762	CbGbCtD
Efavirenz—CYP1A2—Etoposide—sarcoma	0.0125	0.0655	CbGbCtD
Efavirenz—CYP3A4—Mitoxantrone—sarcoma	0.0104	0.0544	CbGbCtD
Efavirenz—CYP3A4—Vincristine—sarcoma	0.00716	0.0374	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—sarcoma	0.00704	0.0368	CbGbCtD
Efavirenz—CYP3A4—Etoposide—sarcoma	0.00657	0.0343	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—sarcoma	0.00448	0.0234	CbGbCtD
Efavirenz—Urticaria—Mitoxantrone—sarcoma	8.53e-05	0.00107	CcSEcCtD
Efavirenz—Breast disorder—Doxorubicin—sarcoma	8.51e-05	0.00107	CcSEcCtD
Efavirenz—Anorexia—Etoposide—sarcoma	8.51e-05	0.00107	CcSEcCtD
Efavirenz—Diarrhoea—Thiotepa—sarcoma	8.5e-05	0.00107	CcSEcCtD
Efavirenz—Abdominal pain—Mitoxantrone—sarcoma	8.48e-05	0.00107	CcSEcCtD
Efavirenz—Body temperature increased—Mitoxantrone—sarcoma	8.48e-05	0.00107	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Doxorubicin—sarcoma	8.48e-05	0.00107	CcSEcCtD
Efavirenz—Diarrhoea—Dactinomycin—sarcoma	8.44e-05	0.00106	CcSEcCtD
Efavirenz—Nasopharyngitis—Doxorubicin—sarcoma	8.42e-05	0.00106	CcSEcCtD
Efavirenz—Pancytopenia—Epirubicin—sarcoma	8.36e-05	0.00105	CcSEcCtD
Efavirenz—Muscular weakness—Doxorubicin—sarcoma	8.31e-05	0.00104	CcSEcCtD
Efavirenz—Dizziness—Thiotepa—sarcoma	8.22e-05	0.00103	CcSEcCtD
Efavirenz—Abdominal distension—Doxorubicin—sarcoma	8.2e-05	0.00103	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Epirubicin—sarcoma	8.18e-05	0.00103	CcSEcCtD
Efavirenz—Asthma—Doxorubicin—sarcoma	8.14e-05	0.00102	CcSEcCtD
Efavirenz—Hypersensitivity—Vincristine—sarcoma	8.12e-05	0.00102	CcSEcCtD
Efavirenz—Photosensitivity reaction—Epirubicin—sarcoma	8.03e-05	0.00101	CcSEcCtD
Efavirenz—Paraesthesia—Etoposide—sarcoma	8.02e-05	0.00101	CcSEcCtD
Efavirenz—Pancreatitis—Doxorubicin—sarcoma	7.98e-05	0.001	CcSEcCtD
Efavirenz—Dyspnoea—Etoposide—sarcoma	7.96e-05	0.000999	CcSEcCtD
Efavirenz—Hyperglycaemia—Epirubicin—sarcoma	7.94e-05	0.000997	CcSEcCtD
Efavirenz—Somnolence—Etoposide—sarcoma	7.94e-05	0.000996	CcSEcCtD
Efavirenz—Hypersensitivity—Mitoxantrone—sarcoma	7.91e-05	0.000993	CcSEcCtD
Efavirenz—Asthenia—Vincristine—sarcoma	7.91e-05	0.000993	CcSEcCtD
Efavirenz—Vomiting—Thiotepa—sarcoma	7.9e-05	0.000992	CcSEcCtD
Efavirenz—Pneumonia—Epirubicin—sarcoma	7.89e-05	0.000991	CcSEcCtD
Efavirenz—Infestation NOS—Epirubicin—sarcoma	7.85e-05	0.000985	CcSEcCtD
Efavirenz—Infestation—Epirubicin—sarcoma	7.85e-05	0.000985	CcSEcCtD
Efavirenz—Drowsiness—Epirubicin—sarcoma	7.85e-05	0.000985	CcSEcCtD
Efavirenz—Vomiting—Dactinomycin—sarcoma	7.84e-05	0.000985	CcSEcCtD
Efavirenz—Rash—Thiotepa—sarcoma	7.84e-05	0.000984	CcSEcCtD
Efavirenz—Dermatitis—Thiotepa—sarcoma	7.83e-05	0.000983	CcSEcCtD
Efavirenz—Headache—Thiotepa—sarcoma	7.79e-05	0.000977	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Epirubicin—sarcoma	7.78e-05	0.000977	CcSEcCtD
Efavirenz—Rash—Dactinomycin—sarcoma	7.78e-05	0.000976	CcSEcCtD
Efavirenz—Decreased appetite—Etoposide—sarcoma	7.76e-05	0.000974	CcSEcCtD
Efavirenz—Pancytopenia—Doxorubicin—sarcoma	7.73e-05	0.000971	CcSEcCtD
Efavirenz—Renal failure—Epirubicin—sarcoma	7.71e-05	0.000968	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Etoposide—sarcoma	7.71e-05	0.000968	CcSEcCtD
Efavirenz—Asthenia—Mitoxantrone—sarcoma	7.7e-05	0.000967	CcSEcCtD
Efavirenz—Fatigue—Etoposide—sarcoma	7.7e-05	0.000966	CcSEcCtD
Efavirenz—Neuropathy peripheral—Epirubicin—sarcoma	7.69e-05	0.000966	CcSEcCtD
Efavirenz—Jaundice—Epirubicin—sarcoma	7.65e-05	0.00096	CcSEcCtD
Efavirenz—Pain—Etoposide—sarcoma	7.63e-05	0.000958	CcSEcCtD
Efavirenz—Constipation—Etoposide—sarcoma	7.63e-05	0.000958	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—sarcoma	7.57e-05	0.00095	CcSEcCtD
Efavirenz—Diarrhoea—Vincristine—sarcoma	7.54e-05	0.000947	CcSEcCtD
Efavirenz—Sweating—Epirubicin—sarcoma	7.52e-05	0.000944	CcSEcCtD
Efavirenz—Haematuria—Epirubicin—sarcoma	7.48e-05	0.000939	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—sarcoma	7.43e-05	0.000933	CcSEcCtD
Efavirenz—Hepatobiliary disease—Epirubicin—sarcoma	7.42e-05	0.000932	CcSEcCtD
Efavirenz—Nausea—Thiotepa—sarcoma	7.38e-05	0.000927	CcSEcCtD
Efavirenz—Sinusitis—Epirubicin—sarcoma	7.36e-05	0.000924	CcSEcCtD
Efavirenz—Feeling abnormal—Etoposide—sarcoma	7.36e-05	0.000924	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—sarcoma	7.34e-05	0.000922	CcSEcCtD
Efavirenz—Diarrhoea—Mitoxantrone—sarcoma	7.34e-05	0.000922	CcSEcCtD
Efavirenz—Nausea—Dactinomycin—sarcoma	7.33e-05	0.00092	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—sarcoma	7.3e-05	0.000917	CcSEcCtD
Efavirenz—Gastrointestinal pain—Etoposide—sarcoma	7.3e-05	0.000916	CcSEcCtD
Efavirenz—Dizziness—Vincristine—sarcoma	7.29e-05	0.000915	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—sarcoma	7.26e-05	0.000911	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—sarcoma	7.26e-05	0.000911	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—sarcoma	7.26e-05	0.000911	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—sarcoma	7.2e-05	0.000904	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—sarcoma	7.14e-05	0.000896	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—sarcoma	7.12e-05	0.000893	CcSEcCtD
Efavirenz—Urticaria—Etoposide—sarcoma	7.09e-05	0.00089	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—sarcoma	7.08e-05	0.000888	CcSEcCtD
Efavirenz—Rhinitis—Epirubicin—sarcoma	7.06e-05	0.000887	CcSEcCtD
Efavirenz—Body temperature increased—Etoposide—sarcoma	7.06e-05	0.000886	CcSEcCtD
Efavirenz—Abdominal pain—Etoposide—sarcoma	7.06e-05	0.000886	CcSEcCtD
Efavirenz—Hepatitis—Epirubicin—sarcoma	7.04e-05	0.000884	CcSEcCtD
Efavirenz—Hypoaesthesia—Epirubicin—sarcoma	7.01e-05	0.00088	CcSEcCtD
Efavirenz—Vomiting—Vincristine—sarcoma	7.01e-05	0.00088	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—sarcoma	6.96e-05	0.000874	CcSEcCtD
Efavirenz—Urinary tract disorder—Epirubicin—sarcoma	6.96e-05	0.000873	CcSEcCtD
Efavirenz—Rash—Vincristine—sarcoma	6.95e-05	0.000872	CcSEcCtD
Efavirenz—Dermatitis—Vincristine—sarcoma	6.94e-05	0.000872	CcSEcCtD
Efavirenz—Oedema peripheral—Epirubicin—sarcoma	6.94e-05	0.000871	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—sarcoma	6.92e-05	0.000869	CcSEcCtD
Efavirenz—Connective tissue disorder—Epirubicin—sarcoma	6.92e-05	0.000869	CcSEcCtD
Efavirenz—Urethral disorder—Epirubicin—sarcoma	6.9e-05	0.000867	CcSEcCtD
Efavirenz—Headache—Vincristine—sarcoma	6.9e-05	0.000867	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—sarcoma	6.87e-05	0.000862	CcSEcCtD
Efavirenz—Vomiting—Mitoxantrone—sarcoma	6.82e-05	0.000857	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—sarcoma	6.81e-05	0.000855	CcSEcCtD
Efavirenz—Visual impairment—Epirubicin—sarcoma	6.79e-05	0.000852	CcSEcCtD
Efavirenz—Rash—Mitoxantrone—sarcoma	6.77e-05	0.00085	CcSEcCtD
Efavirenz—Dermatitis—Mitoxantrone—sarcoma	6.76e-05	0.000849	CcSEcCtD
Efavirenz—Headache—Mitoxantrone—sarcoma	6.72e-05	0.000844	CcSEcCtD
Efavirenz—Erythema multiforme—Epirubicin—sarcoma	6.66e-05	0.000836	CcSEcCtD
Efavirenz—Eye disorder—Epirubicin—sarcoma	6.58e-05	0.000826	CcSEcCtD
Efavirenz—Hypersensitivity—Etoposide—sarcoma	6.58e-05	0.000826	CcSEcCtD
Efavirenz—Tinnitus—Epirubicin—sarcoma	6.57e-05	0.000824	CcSEcCtD
Efavirenz—Nausea—Vincristine—sarcoma	6.55e-05	0.000822	CcSEcCtD
Efavirenz—Cardiac disorder—Epirubicin—sarcoma	6.54e-05	0.000821	CcSEcCtD
Efavirenz—Flushing—Epirubicin—sarcoma	6.54e-05	0.000821	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—sarcoma	6.53e-05	0.00082	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—sarcoma	6.52e-05	0.000818	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—sarcoma	6.48e-05	0.000814	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—sarcoma	6.44e-05	0.000808	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—sarcoma	6.42e-05	0.000806	CcSEcCtD
Efavirenz—Asthenia—Etoposide—sarcoma	6.41e-05	0.000804	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—sarcoma	6.4e-05	0.000804	CcSEcCtD
Efavirenz—Angiopathy—Epirubicin—sarcoma	6.39e-05	0.000802	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—sarcoma	6.39e-05	0.000802	CcSEcCtD
Efavirenz—Nausea—Mitoxantrone—sarcoma	6.37e-05	0.0008	CcSEcCtD
Efavirenz—Immune system disorder—Epirubicin—sarcoma	6.36e-05	0.000799	CcSEcCtD
Efavirenz—Mediastinal disorder—Epirubicin—sarcoma	6.35e-05	0.000797	CcSEcCtD
Efavirenz—Pruritus—Etoposide—sarcoma	6.32e-05	0.000793	CcSEcCtD
Efavirenz—Arrhythmia—Epirubicin—sarcoma	6.29e-05	0.00079	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—sarcoma	6.28e-05	0.000788	CcSEcCtD
Efavirenz—Alopecia—Epirubicin—sarcoma	6.22e-05	0.000781	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—sarcoma	6.16e-05	0.000774	CcSEcCtD
Efavirenz—Erythema—Epirubicin—sarcoma	6.13e-05	0.00077	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—sarcoma	6.13e-05	0.00077	CcSEcCtD
Efavirenz—Diarrhoea—Etoposide—sarcoma	6.11e-05	0.000767	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—sarcoma	6.09e-05	0.000765	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—sarcoma	6.08e-05	0.000763	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—sarcoma	6.05e-05	0.000759	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—sarcoma	6.05e-05	0.000759	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—sarcoma	6.04e-05	0.000759	CcSEcCtD
Efavirenz—Tension—Epirubicin—sarcoma	6.02e-05	0.000755	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—sarcoma	6e-05	0.000754	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—sarcoma	5.96e-05	0.000748	CcSEcCtD
Efavirenz—Back pain—Epirubicin—sarcoma	5.93e-05	0.000745	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—sarcoma	5.91e-05	0.000742	CcSEcCtD
Efavirenz—Dizziness—Etoposide—sarcoma	5.9e-05	0.000741	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—sarcoma	5.89e-05	0.000739	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—sarcoma	5.87e-05	0.000737	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—sarcoma	5.82e-05	0.000731	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—sarcoma	5.78e-05	0.000725	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—sarcoma	5.76e-05	0.000723	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—sarcoma	5.69e-05	0.000714	CcSEcCtD
Efavirenz—Vomiting—Etoposide—sarcoma	5.68e-05	0.000713	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—sarcoma	5.67e-05	0.000712	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—sarcoma	5.67e-05	0.000712	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—sarcoma	5.67e-05	0.000711	CcSEcCtD
Efavirenz—Agitation—Epirubicin—sarcoma	5.63e-05	0.000707	CcSEcCtD
Efavirenz—Rash—Etoposide—sarcoma	5.63e-05	0.000707	CcSEcCtD
Efavirenz—Dermatitis—Etoposide—sarcoma	5.62e-05	0.000706	CcSEcCtD
Efavirenz—Headache—Etoposide—sarcoma	5.59e-05	0.000702	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—sarcoma	5.59e-05	0.000702	CcSEcCtD
Efavirenz—Tension—Doxorubicin—sarcoma	5.57e-05	0.000699	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—sarcoma	5.56e-05	0.000697	CcSEcCtD
Efavirenz—Malaise—Epirubicin—sarcoma	5.53e-05	0.000694	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—sarcoma	5.51e-05	0.000692	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—sarcoma	5.51e-05	0.000692	CcSEcCtD
Efavirenz—Syncope—Epirubicin—sarcoma	5.5e-05	0.00069	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—sarcoma	5.49e-05	0.000689	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—sarcoma	5.42e-05	0.00068	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—sarcoma	5.39e-05	0.000677	CcSEcCtD
Efavirenz—Cough—Epirubicin—sarcoma	5.35e-05	0.000672	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—sarcoma	5.35e-05	0.000671	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—sarcoma	5.31e-05	0.000667	CcSEcCtD
Efavirenz—Nausea—Etoposide—sarcoma	5.3e-05	0.000666	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—sarcoma	5.29e-05	0.000665	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—sarcoma	5.26e-05	0.000661	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—sarcoma	5.24e-05	0.000658	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—sarcoma	5.22e-05	0.000655	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—sarcoma	5.22e-05	0.000655	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—sarcoma	5.22e-05	0.000655	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—sarcoma	5.21e-05	0.000655	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—sarcoma	5.2e-05	0.000653	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	5.18e-05	0.000651	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—sarcoma	5.16e-05	0.000647	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—sarcoma	5.12e-05	0.000642	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—sarcoma	5.11e-05	0.000641	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—sarcoma	5.1e-05	0.00064	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—sarcoma	5.09e-05	0.000639	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—sarcoma	5.05e-05	0.000633	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—sarcoma	5.01e-05	0.000629	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—sarcoma	4.99e-05	0.000626	CcSEcCtD
Efavirenz—Cough—Doxorubicin—sarcoma	4.95e-05	0.000622	CcSEcCtD
Efavirenz—Shock—Epirubicin—sarcoma	4.92e-05	0.000618	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—sarcoma	4.92e-05	0.000617	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—sarcoma	4.91e-05	0.000616	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—sarcoma	4.9e-05	0.000615	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—sarcoma	4.9e-05	0.000615	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—sarcoma	4.88e-05	0.000613	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—sarcoma	4.86e-05	0.00061	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—sarcoma	4.84e-05	0.000607	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—sarcoma	4.83e-05	0.000606	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—sarcoma	4.83e-05	0.000606	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—sarcoma	4.83e-05	0.000606	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—sarcoma	4.81e-05	0.000604	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	4.8e-05	0.000602	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—sarcoma	4.77e-05	0.000599	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—sarcoma	4.77e-05	0.000599	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—sarcoma	4.72e-05	0.000593	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—sarcoma	4.67e-05	0.000586	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—sarcoma	4.56e-05	0.000572	CcSEcCtD
Efavirenz—Shock—Doxorubicin—sarcoma	4.56e-05	0.000572	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—sarcoma	4.54e-05	0.00057	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—sarcoma	4.53e-05	0.000569	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—sarcoma	4.53e-05	0.000568	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—sarcoma	4.52e-05	0.000567	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—sarcoma	4.5e-05	0.000565	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—sarcoma	4.49e-05	0.000564	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—sarcoma	4.48e-05	0.000562	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—sarcoma	4.46e-05	0.00056	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—sarcoma	4.45e-05	0.000558	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—sarcoma	4.41e-05	0.000554	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—sarcoma	4.4e-05	0.000553	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—sarcoma	4.35e-05	0.000546	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—sarcoma	4.32e-05	0.000542	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—sarcoma	4.31e-05	0.000542	CcSEcCtD
Efavirenz—Pain—Epirubicin—sarcoma	4.28e-05	0.000537	CcSEcCtD
Efavirenz—Constipation—Epirubicin—sarcoma	4.28e-05	0.000537	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—sarcoma	4.22e-05	0.00053	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—sarcoma	4.19e-05	0.000526	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—sarcoma	4.16e-05	0.000522	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—sarcoma	4.13e-05	0.000518	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—sarcoma	4.12e-05	0.000518	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—sarcoma	4.12e-05	0.000517	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—sarcoma	4.09e-05	0.000514	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—sarcoma	4.08e-05	0.000512	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—sarcoma	4.03e-05	0.000505	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—sarcoma	4e-05	0.000502	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—sarcoma	3.99e-05	0.000501	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—sarcoma	3.98e-05	0.000499	CcSEcCtD
Efavirenz—Pain—Doxorubicin—sarcoma	3.96e-05	0.000497	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—sarcoma	3.96e-05	0.000497	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—sarcoma	3.96e-05	0.000497	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—sarcoma	3.96e-05	0.000497	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—sarcoma	3.82e-05	0.000479	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—sarcoma	3.79e-05	0.000475	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—sarcoma	3.69e-05	0.000463	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—sarcoma	3.68e-05	0.000462	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—sarcoma	3.66e-05	0.00046	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—sarcoma	3.66e-05	0.00046	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—sarcoma	3.59e-05	0.000451	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—sarcoma	3.54e-05	0.000444	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—sarcoma	3.42e-05	0.00043	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—sarcoma	3.41e-05	0.000428	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—sarcoma	3.32e-05	0.000417	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—sarcoma	3.31e-05	0.000415	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—sarcoma	3.28e-05	0.000411	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—sarcoma	3.18e-05	0.000399	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—sarcoma	3.17e-05	0.000398	CcSEcCtD
Efavirenz—Rash—Epirubicin—sarcoma	3.16e-05	0.000396	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—sarcoma	3.15e-05	0.000396	CcSEcCtD
Efavirenz—Headache—Epirubicin—sarcoma	3.13e-05	0.000394	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—sarcoma	3.06e-05	0.000384	CcSEcCtD
Efavirenz—Nausea—Epirubicin—sarcoma	2.97e-05	0.000373	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—sarcoma	2.94e-05	0.00037	CcSEcCtD
Efavirenz—Rash—Doxorubicin—sarcoma	2.92e-05	0.000367	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—sarcoma	2.92e-05	0.000366	CcSEcCtD
Efavirenz—Headache—Doxorubicin—sarcoma	2.9e-05	0.000364	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—sarcoma	2.75e-05	0.000345	CcSEcCtD
